HPV prevents cancer. That’s the headline. It’s now on the routine schedule for all kids starting at 9-12, and the earlier it’s given the fewer doses are needed.
What it protects against
Human papillomavirus — the virus responsible for nearly all cervical cancers and a large share of other cancers including oropharyngeal (throat), anal, vulvar, vaginal, and penile. HPV is also the cause of genital warts.
When it’s given
Per the CDC schedule: routine at 11-12, can start as early as 9. Two doses are needed if started before age 15 (second dose 6-12 months after first). Three doses if started at 15 or later. Recommended for all kids — boys and girls.
Common side effects
Soreness, swelling, and sometimes bruising at the injection site. Brief dizziness or fainting is relatively common with this vaccine (and with any adolescent vaccine), so pediatricians usually have kids sit or lie down for a few minutes after. Mild fever and headache for some.
Common questions
“Why so young?” The vaccine works by building immunity before any exposure, and immune response is strongest at this age — hence the shift to starting at 9-12 rather than later. “Does it give kids permission to do anything?” The research is clear: HPV vaccination doesn’t change behavior. It just prevents the virus and the cancers it causes. “Do boys need it?” Yes — they get HPV-related cancers too, and reducing transmission protects everyone.
Questions worth asking
- Are we starting at 9, 11, or later?
- Is this a two-dose or three-dose series given our timing?
- Can we do this at the back-to-school visit?
How VisitRecall fits in
Two- or three-dose series over months is exactly the kind of thing that slips. Follow-ups, health journal, parents hub.
FAQ
Is HPV vaccine required for school?
Not in most states — it’s on the routine schedule but not usually a school requirement.
My kid is already a teenager — is it too late?
No — it’s approved and recommended through 26, with shared decision-making up to 45.
Long-term safety data?
HPV vaccines have been in wide use since 2006. The safety data is extensive.